Addressing Barriers to Palliative Care Use in Bladder Cancer
- Conditions
- Muscle-Invasive Bladder CarcinomaBladder Cancer Stage IIIBladder Cancer Stage IIBladder Cancer Stage IV
- Registration Number
- NCT04598724
- Brief Summary
Investigators plan to establish an in-depth understanding of knowledge and beliefs about palliative care in advanced Bladder Cancer patients and their caregivers, and to identify factors associated with positive and negative experiences with palliative care services among those who have received them.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 54
- Eligibility for both patient and caregiver participants will include:
- age ≥18 years
- able to speak and read English
- cognitively able to participate in study tasks
- willing to participate in surveys, semi-structured interviews, and/or focus groups
- able to participate in either a Zoom meeting or phone interview
- able to complete an emailed or paper survey
- Patient Participants: a diagnosis of muscle-invasive or locally advanced bladder cancer (stages II-IV).
- Patients and caregivers will be excluded if unable to provide verbal or written consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion with accurate palliative care knowledge and beliefs 12 Months Proportion of patients correctly answering each palliative care knowledge question.
Development of palliative care knowledge and beliefs 12 Months Thematic analysis of interviews transcriptions to identify the themes that underpin the development of palliative care beliefs among patients with muscle invasive bladder cancer.
- Secondary Outcome Measures
Name Time Method Association between Bladder Cancer stage and palliative care knowledge 12 Months Analysis of variance calculated for the mean number of subjects with each cancer stage correctly answering each palliative care knowledge question
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Moffitt Cancer Center
🇺🇸Tampa, Florida, United States
Moffitt Cancer Center🇺🇸Tampa, Florida, United States